bluebird bio effects 1-for-20 reverse stock split; shares trade split-adjusted Dec 13

bluebird bio, Inc.

Effective Dec 12, 2024 at 5:00 p.m. ET; new CUSIP 09609G 209.
Every 20 pre-split shares convert to 1 share; no fractional shares issued.
Authorized shares and par value unchanged; trading symbol remains BLUE.
Split approved by stockholders Dec 4, 2024; board chose 1-for-20 ratio.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

bluebird bio, Inc.: Effected a 1-for-20 reverse stock split of common stock via a Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective 2024-12-12).

Change: charter amendment
Effective: 2024-12-12

Exact text from the filing

On December 12, 2024, bluebird bio, Inc. (the "Company") filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended (the "Charter Amendment") with the Secretary of State of the State of Delaware to effect a 1-for-20 reverse stock split (the "Reverse Stock Split") of the Company's common stock, par value $0.01 per share (the "Common Stock"), effective December 12, 2024 at 5:00 p.m., Eastern Time (the "Effective Time")

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001293971-24-000090

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.